| 产品描述: | rel-Zotatifin is the racemic isomer of Zotatifin, acts as an eIF4A inhibitor with activity less than Zotatifin. Zotatifin (eFT226) is a potent, selective, and well-tolerated eIF4A inhibitor. Zotatifin promotes eIF4A binding to specific mRNA sequences with recognition motifs in the 5’-UTRs (IC50=2 nM) and interferes with the assembly of the eIF4F initiation complex. |
| 参考文献: |
1. Peggy A. Thompson, et al. Preclinical Evaluation of eFT226, a Novel, Potent and Selective eIF4A Inhibitor with Anti-tumor Activity in B-cell Malignancies. 2. Gordon DE, et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing 웿 |
| 保存条件: |
-20°C |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.051 ml |
10.255 ml |
20.51 ml |
| 5 mM |
0.41 ml |
2.051 ml |
4.102 ml |
| 10 mM |
0.205 ml |
1.026 ml |
2.051 ml |
| 50 mM |
0.041 ml |
0.205 ml |
0.41 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |